cannabis
Why Synthetic THC Patents Hide Cannabis Benefits
57% of certified epilepsy patients are still uninsured for FDA-approved THC medication because patent restrictions force companies to charge sky-high prices. The patents cover synthetic versions of THC, locking out cheaper plant-based alternatives and leaving vulnerable families without affordable treatment. Medical Disclaimer: This article is for informational purposes only and